| Cat. No. |
Product Name / Activity |
| 6602 |
1M7 |
| Reagent for RNA SHAPE-MaP chemistry |
| 7376 |
2A3 |
| Reagent for RNA SHAPE-MaP experiments in vivo; cell permeable |
| 3771 |
Azithromycin |
| Antibiotic; inhibits 50S ribosomal subunit formation and elongation at transpeptidation |
| 5015 |
5-BrdU |
| Synthetic thymidine analog; used for cell proliferation assays |
| 8108 |
CEP |
| Chemoproteomic reagent, clickable electrophilic purine for RNA binding profiling in live cells |
| 4091 |
Cyclophosphamide |
| Alkylating agent; chemotherapeutic |
| 4090 |
Doxycycline hyclate |
| Regulator for inducible gene expression systems; also broad-spectrum antibiotic and MMP inhibitor |
| 7207 |
5-Ethynyl-2'-deoxyuridine |
| Thymidine analog for labeling DNA; can be linked to a fluorophore by click chemistry |
| 7206 |
5-Ethynyluridine |
| Uridine analog, used for labeling RNA synthesis |
| 8011 |
FAI |
| Reagent for RNA SHAPE-MaP experiments in live cells |
| 5075 |
Harmine |
| Binds to the yjdF aptamer; activates riboswitch function; also DYRK1A inhibitor |
| 6782 |
Indisulam |
| Pre-mRNA splicing modulator; hCA XII inhibitor |
| 5284 |
trans-ISRIB |
| Integrated stress response (ISR) inhibitor |
| 5185 |
JTE 607 dihydrochloride |
| Active metabolite binds CPSF3; Pro-drug |
| 7942 |
Lac-Phe |
| Metabolite generated by cytosol nonspecific dipeptidase (CNDP2) during intense exercise |
| 7586 |
Molnupiravir |
| Prodrug of antiviral nucleoside analog; inhibits SARS-CoV, SARS-CoV-2 and MERS-CoV infection |
| 7004 |
NAI |
| Reagent for RNA SHAPE-MaP experiments in vivo; cell permeable |
| 7974 |
P3S |
| Reagent for modifying RNA at 2'-OH position, for SHAPE-MAP experiments |
| 6862 |
Psoralen-triethylene glycol azide |
| RNA conformation probe; reagent for COMRADES RNA platform |
| 7916 |
Risdiplam |
| Selective SMN2 gene splicing modifier |